• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Sanofi, Cambridge, United States, Cambridge, MA

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Tolebrutinib Versus Placebo in Non-relapsing Secondary Progressive Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 HERCULES Trial

Author:Fox, Robert J.   Bar-Or, Amit   Traboulsee, Anthony   Oreja-Guevara, Celia   Giovannoni, Gavin   Vermersch, Patrick   Syed, Sana   Li, Ye   Vargas, Wendy S.   Turner, Timothy J.   Wallstroem, Erik   Reich, Daniel S.   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL5.003  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, Cleveland, OH  Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, Philadelphia, PA  The University of British Columbia, Division of Neurology, Vancouver, Canada, Vancouver, BC, Canada  Multiple Sclerosis Center, University Hospital San Carlos, Madrid, Spain, Madrid, Spain  Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, London, United Kingdom  University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, Lille, France  Sanofi, Cambridge, United States, Cambridge, MA  Sanofi, Bridgewater, United States, Bridgewater, NJ  Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, Bethesda, MD  

  • View Abstract
  • View Disclosure

Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 GEMINI 1 and 2 Trials

Author:Oh, Jiwon   Arnold, Douglas L.   Cree, Bruce A.C.   Ionete, Carolina   Kim, Ho Jin   Sormani, Maria Pia   Syed, Sana   Chen, Yixin   Maxwell, Christina R.   Benoit, Patrick   Turner, Timothy J.   Wallstroem, Erik   Wiendl, Heinz   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL5.008  

Author Institution:St. Michael’s Hospital, University of Toronto, Toronto, Canada, Toronto, ON, Canada  NeuroRx Research, Montréal, Canada, Montreal, QC, Canada  UCSF Weill Institute for Neurosciences, University of California San Francisco, Department of Neurology, San Francisco, United States, San Francisco, CA  UMass Chan Medical School, Worcester, United States, WORCESTER, MA  National Cancer Center, Department of Neurology, Goyang, South Korea, Goyang, Korea, Republic of  University of Genoa, Department of Health Sciences, Genoa, Italy, Genoa, Italy  Sanofi, Cambridge, United States, Cambridge, MA  Sanofi, Cambridge, United States, Mullica Hill, NJ  Sanofi, Chilly-Mazarin, France, Chilly Mazarin, France  Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany, Muenster, Germany  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com